Although further research is needed to delineate the precise mechanisms and develop targeted interventions, these findings underscore the central role of hepatic AhR in metabolic homeostasis and suggest that modulation of hepatic AhR activity could be a promising strategy for treating obesity and related metabolic disorders. The gene discussed is AHR; the disease is obesity due to melanocortin 4 receptor deficiency.